Genmab | GEN - Capitalización De Mercado

Precio De Mercado
1,690.00
Cambio Diario
35.00 2.11%
Mensual
-1.34%
Anual
20.80%
Q2 Expectativa
1,628.53




Capitalización De Mercado Cambio Fecha
Agios Pharmaceuticals USD 1.6B 410M 2026-04
Almirall EUR 2.76B 472.53M 2025-12
Amarin USD 290M 51M 2025-12
Amgen USD 187.49B 11.24B 2026-04
argenx SE USD 51.83B 7.52B 2025-12
AstraZeneca USD 214.75B 86.5B 2026-04
Bayer EUR 36.36B 9.13B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Demant DKK 46.01B 10.48B 2025-12
Exelixis USD 11.75B 959M 2025-12
Fresenius Medical Care EUR 11.96B 1.14B 2025-12
Galapagos EUR 1.85B 76.44M 2025-12
Genmab DKK 20.48B 1.02B 2025-12
GlaxoSmithKline GBP 80.41B 3.39B 2026-04
GN Store Nord DKK 16.11B 98.09M 2025-12
GRIFOLS EUR 3.78B 3.71B 2026-04
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Insmed USD 37.12B 6.68B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 53.3B 5.72B 2025-12
Novartis USD 231.75B 76B 2026-04
Regeneron Pharmaceuticals USD 75.34B 6.35B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
UCB EUR 46.41B 13.94B 2025-12